Literature DB >> 10607764

Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.

T Kokubo1, K Hashizume, H Iwase, K Arai, A Tanaka, K Toma, K Hotta, Y Kobayashi.   

Abstract

BACKGROUND: The human IgA1 hinge region is a unique mucin-like O-linked proline-rich glycopeptide, and its core peptide was found to be exposed aberrantly by the underglycosylation in IgA nephropathy (IgAN). We describe here the presence of humoral immunity against the IgA1 hinge peptide epitope in IgAN and evaluate the relationship between the underglycosylation of the IgA1 hinge region and humoral immunity.
METHOD: The serum anti-IgA1 hinge peptide antibody (anti-alpha1HP ab) titre was measured and compared between the IgAN (n=37) and control groups (n=34) by enzyme-linked immunosorbent assay (ELISA) using a synthetic peptide corresponding to the human IgA1 hinge region, PVPSTPPTPSPSTPPTPSPS, as an antigen. Next, to evaluate the relationship between the underglycosylation of the IgA1 hinge region and the humoral immunity, the reactivity of the serum IgG from the patients with IgAN against monoclonal IgA1 which had been digested enzymatically to remove the carbohydrates from the IgA1 hinge region was measured by ELISA.
RESULTS: The anti-alpha1HP ab titre was significantly higher in the IgAN group than in the control group (OD value: IgG class, 0.564+/-0.344 vs 0. 331+/-0.154, P=0.0014; IgM class, 0.272+/-0.148 vs 0.141+/-0.072, P<0.0001) and it was positive in approximately 40% of the patients with IgAN. In addition, the reactivity of the serum IgG from the IgAN patients against the monoclonal IgA1 was found to be increased as the carbohydrates were enzymatically removed from the IgA1 hinge region (when native=100; asialo, 122+/-9.5; agalacto, 167+/-11.5; naked, 188+/-3.9).
CONCLUSION: These results suggested that the peptide epitope of the IgA1 hinge region which was aberrantly exposed by underglycosylation could induce the humoral immune response in IgAN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607764     DOI: 10.1093/ndt/15.1.28

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Label-free optical detection of peptide synthesis on a porous silicon scaffold/sensor.

Authors:  Patrick Furbert; Caiyan Lu; Nicholas Winograd; Lisa DeLouise
Journal:  Langmuir       Date:  2008-02-05       Impact factor: 3.882

3.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

Authors:  Takeshi Yanagihara; Rhubell Brown; Stacy Hall; Zina Moldoveanu; Alice Goepfert; Milan Tomana; Bruce A Julian; Jiri Mestecky; Jan Novak
Journal:  Results Immunol       Date:  2012-01-01

5.  IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

Authors:  Jan Novak; Leona Raskova Kafkova; Hitoshi Suzuki; Milan Tomana; Karel Matousovic; Rhubell Brown; Stacy Hall; John T Sanders; T Matthew Eison; Zina Moldoveanu; Lea Novak; Zdenek Novak; Richard Mayne; Bruce A Julian; Jiri Mestecky; Robert J Wyatt
Journal:  Nephrol Dial Transplant       Date:  2011-08-09       Impact factor: 5.992

Review 6.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

7.  Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1.

Authors:  Yoshiyuki Hiki; Kazuo Takahashi; Sachiko Shimozato; Hiroko Odani; Kouichirou Yamamoto; Makoto Tomita; Midori Hasegawa; Kazutaka Murakami; Kunihiro Nabeshima; Shigeru Nakai; Yoshiroh Fujita; Isao Ishida; Hitoo Iwase; Satoshi Sugiyama
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

Review 8.  O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy.

Authors:  Yoshiyuki Hiki
Journal:  Clin Exp Nephrol       Date:  2009-04-15       Impact factor: 2.801

9.  Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

Authors:  Milan Raska; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Rose Kulhavy; Judit Andrasi; Stacy Hall; Huong L Vu; Fredric Carlsson; Gunnar Lindahl; Milan Tomana; Bruce A Julian; Robert J Wyatt; Jiri Mestecky; Jan Novak
Journal:  J Mol Biol       Date:  2007-03-12       Impact factor: 5.469

10.  Do the mutations of C1GALT1C1 gene play important roles in the genetic susceptibility to Chinese IgA nephropathy?

Authors:  Gui-Sen Li; Guang-Jun Nie; Hong Zhang; Ji-Cheng LV; Yan Shen; Hai-Yan Wang
Journal:  BMC Med Genet       Date:  2009-09-24       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.